Arrhythmic Mitral Valve Prolapse clinical trials

Explore recruiting arrhythmic mitral valve prolapse clinical trials.

Recruiting arrhythmic mitral valve prolapse studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Arrhythmic Mitral Valve Prolapse trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Investigator-Initiated Prospective Randomized Open-Label Blinded-Endpoint Crossover Trial Comparing the Effect and Safety of Flecainide and Metoprolol versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse (FLECAPRO).

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Arrhythmic Mitral Valve Prolapse trials by city

Arrhythmic Mitral Valve Prolapse in Toronto Arrhythmic Mitral Valve Prolapse in Vancouver Arrhythmic Mitral Valve Prolapse in Montreal Arrhythmic Mitral Valve Prolapse in Calgary Arrhythmic Mitral Valve Prolapse in Edmonton Arrhythmic Mitral Valve Prolapse in Ottawa Arrhythmic Mitral Valve Prolapse in Winnipeg Arrhythmic Mitral Valve Prolapse in Quebec City Arrhythmic Mitral Valve Prolapse in Hamilton Arrhythmic Mitral Valve Prolapse in Kitchener Arrhythmic Mitral Valve Prolapse in London Arrhythmic Mitral Valve Prolapse in Halifax Arrhythmic Mitral Valve Prolapse in New York Arrhythmic Mitral Valve Prolapse in Los Angeles Arrhythmic Mitral Valve Prolapse in Chicago Arrhythmic Mitral Valve Prolapse in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease